Diallyl polysulfanes, such as diallyl trisulfide and diallyl tetrasulfide, are regarded as a group of potential chemopreventive compounds as they have been proven to be effective inhibitors of cancer cells. These agents have been implicated in signal transductions, including the generation of Reactive Oxygen Species (ROS), Endoplasmic Reticulum (ER) stress, mitogen-activated protein kinase (MAPK) signaling, regulation of cell cycle progression, and induction of apoptosis. Nonetheless, certain aspects of the diallyl polysulfane triggered inhibitory effects on cancer cells are still not clear. Understanding the targeted signaling pathways may help to develop new strategies to treat cancer and other diseases. This review is therefore aimed at addressing the targeting of specific intracellular signal transduction cascades by these diallyl polysulfanes in order to shed some light on possible mechanisms of action of these compounds.
Introduction
The medicinal benefit of garlic (Allium satium) is well known since ancient time. Garlic derived compounds have received increasing attention for many years due to their cancer preventing, diaphoretic, diuretic, and expectorant properties, as well as their antiparasitic effects [1] . Alliums are odorless until the plant cells are cut or crushed or otherwise damaged. After this damage to plant cells, volatile sulfur containing chemicals are generated. Among these, diallyl mono-and polysulfanes, such as di-, tri-and tetrasulfide, are the most studied compounds. From recent studies, it becomes more and more apparent that the diallyl mono-and polysulfanes ( Figure  1A ) are promiscuous because they target multiple signal transduction pathways to exert their anti-proliferative, immunosuppressive and antimicrobial functions. There are various reviews on the properties and functions of diallyl mono-and polysulfanes [2] [3] [4] [5] [6] [7] [8] , including one paper in this issue.
The present review will address particularly the targeting of intracellular signal transduction cascades by diallyl polysulfanes in order to shed some light on possible mechanisms of action of these compounds in human cells. Understanding the targeted signalling pathways may help to develop new strategies to fight cancer and other diseases.
Diallyl polysulfanes and Reactive Oxygen Species (ROS):
Reactive Oxygen Species (ROS) are small, highly reactive molecules that play a vital role in cell signaling. They can be organic or inorganic and their reactivity is mostly due to the unpaired electrons they carry.
They are normally natural byproducts of oxygen metabolism. However, they can also be formed by exogenous sources such as ionizing radiation. The mechanism through which diallyl polysulfanes generate ROS is not quite understood at the moment. The general consensus though is that these polysulfanes react with glutathione (GSH) and are reduced to perthiols that are easily oxidized to perthiyl radicals, which can further react with GSH to form polysulfane radical anions ( Figure 1B) . These then can reduce molecular oxygen to generate ROS (for review, see [4, 9, 10] ). ROS can cause oxidative damage to DNA. The nature of this damage includes mainly base modifications, deoxyribose oxidation, strand breakage and DNA-protein cross-links. All of these of course may lead to tumor progression, mutation and metastasis [11] . ROS production may also interfere with normal cell signaling, resulting thereby in alteration of the gene expression, and development of cancer by redox regulation of transcription factors/activators and/or by oxidatively modulating the protein kinase cascade [12] [13] [14] .
Apoptosis, which will be discussed later in this review, occurs under a variety of physiological conditions that control the development and homeostasis of multicellular organisms. The influence of ROS on the induction of apoptosis either through the death receptor-or mitochondria-dependent pathways has long been established as the best strategy for agents such as garlic organosulfur compounds to kill cancer cells [12, [15] [16] [17] . Furthermore, both pathways are known to be implicated in ER stress induction leading to apoptosis [16, 17] .
induce cytoprotective detoxifying enzymes such as heme oxygenase 1 (HO-1) and NAD(P)H: quinone oxidoreductase -1 (NQO-1) through regulation of ER stress related genes [16, 17, 19] . ROS produced by diallyl polysulfanes have been shown to directly induce transcription factors such as CHOP [17] , ATF3 [20] and Nrf2 [19] , all of which are involved in ER stress signaling.
ROS can cause tissue damage by reacting with sulfhydryl groups in proteins. They can disrupt key cytoskeleton components (such as microfilaments and microtubules) of the cell through modifications of specific cysteine residues of both actin and tubulin [21] . Diallyl disulfide and diallyl trisulfide in particular have been shown to directly oxidize sulfhydryl groups of certain cysteines on the polypeptide chain of tubulin, thereby inhibiting the mitotic spindle [22, 23] .
Diallyl disulfide has been shown to induce ROS in mouse-rat hybrid retina ganglion (N18) cells. In their studies, Lin and colleagues [18] treated N18 cells with various concentrations of diallyl disulfides for 24 h, after which, they examined the level of ROS by flow cytometry using 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA). Their result showed a sharp increase in ROS production within 0.5 h, which reached its maximum level at about 2 h before starting to decrease. Their results suggested that ROS may be an early event in diallyl disulfide-modulated signaling pathways. Similar observations have been reported in glioblastoma [16] , human cervical cancer Ca Ski [24] and human colon COLO 205 cancer [17] cells. It has also been shown that using a ROS scavenger, such as catalase [24] , N-acetylcysteine (NAC) [25] and ascorbic acid [26] , or a mimetic of superoxide dismutase [27] significantly lowers the diallyl polysulfane-induced ROS generation and the amount of cells going into apoptosis [24] .
Diallyl polysulfanes and ER stress
The endoplasmic reticulum (ER) has long been established as a vital organelle in the eukaryotic cell where lipid synthesis, protein folding and maturation and calcium concentrations are regulated. The ER senses and responds to changes within the cell, hence, establishing itself as a major signal transducer. Conditions interfering with the function of the ER are collectively referred to as ER stress. Accumulation of unfolded or misfolded proteins in the ER can provoke ER stress, and as a protective means, these unfolded protein response (UPR) signaling pathways initiate a cell protective machinery aimed at protecting the cells against stressinduced damage [28] . During UPR signaling, a set of ER-resident transmembrane sensors (such as PERK, IRE-1 and ATF6) and ERlocated chaperones, such as the glucose-regulated proteins -Grp78/BiP and Grp94 become activated. The pancreatic ER kinase (PERK), for example, plays a vital role in activating and phosphorylating transcription factors that regulate the expression of genes involved in ER homeostasis. PERK is a Ser/Thr kinase known to activate both eIF2α (eukaryotic initiation factor 2 alpha) and the transcription factor Nrf2 (nuclear factor-E2-related factor 2) [29] . When there is ER stress, PERK promotes suppression of global protein synthesis via the phosphorylation on Ser51 of the alpha subunit of eukaryotic initiation factor 2 (eIF2α). One UPR protein that is selectively translated under these conditions is transcription activating factor 4 (ATF4) [29] . IRE-1 (inositol requiring enzyme 1) and ATF6 (activating transcription factor 6), on the other hand, serve to restore the balance between newly synthesized and correctly matured proteins [30] [31] [32] .
Nrf2 is another protein that is quite often, but not always, involved in ER stress. Phosphorylation of this protein by PERK enables it to dissociate from its cytosolic repressor Keap1 (kelch-like Ech associated protein 1), thus freeing Nrf2 for nuclear translocation, where the latter binds to antioxidant response element (ARE) binding sites. This binding eventually results in the expression of a number of genes implicated in antioxidant stress responses [33, 34] .
The ER, of course, has another means of dealing with excessive stress. In an event where protein aggregation is prolonged and the stress cannot be alleviated, apoptosis can be initiated through the activation of CHOP (CCAAT/enhancer-binding protein homologous protein) and caspase-12 [35] . CHOP is also known as growth-arrest and DNA-damage inducible gene 153 (GADD 153) and is a key pro-apoptotic transcription factor that is closely related to ER stress ( Figure 2 ).
Diallyl disulfide has been shown to induce apoptosis in human colon cancer cells (COLO 205) through the induction of reactive oxygen species (ROS) and ER stress. Work by Yang and colleagues [17] showed that diallyl disulfide promoted the production of ROS and accumulation of Ca 2+ that are associated with the induction of apoptosis in most cancer cells. They showed an increase in both CHOP and the ER-located chaperone -BIP (Grp78) 24 h post treatment with diallyl disulfide. This indeed is in agreement with an earlier finding by Das and colleagues [16] who reported that diallyl sulfide and diallyl disulfide cause ER stress in glioblastoma cells, which is associated with activation of caspase-4, calpain and caspase-3. Over-expression of calreticulin (an ER luminal protein) [36] in glioblastoma cells and treatment with diallyl sulfide and diallyl disulfide resulted in an increase in caspase-4 activation. The latter is localized in the ER and cleaved to the active form in response to ER stress [37] .
It has also been reported that diallyl disulfide induces the upregulation of detoxifying enzymes such as NAD(P)H: quinone oxidoreductase 1 (NQO-1) and heme oxygenase 1 (HO1) genes through the activation and translocation of Nrf2 into the nucleus, where it binds to ARE-binding sites and orchestrates gene expressions [19] .
Diallyl polysulfanes and the mitogen-activated protein kinase (MAPK) signaling pathway
Mitogen-activated protein kinases are a family of serine/threonine kinases that comprise three major subgroups, namely extracellular signal-regulated kinase (ERK), p38 MAPK and c-Jun N-terminal kinases (JNKs). Despite the diversity in function and upstream signaling events, all MAP kinases are activated by phosphorylation of either a threonine or a tyrosine residue. Members of the p38 MAP kinase subgroup play important roles in cytokine production, stress response, cell cycle regulation, developmental processes and differentiation. These family members are activated by cellular stress such as UV irradiation, heat shock, osmotic stress and certain cytokines and growth factors. The ERK pathway is mainly implicated in the regulation of cell growth and differentiation. The signaling cascade leading to ERK activation is induced by a wide variety of growth factors, hormones, cytokines, integrins and ion channels and their corresponding receptors. The signaling cascades finally converge on ERK, which is phosphorylated by MAPK/ERK kinases 1/2 (MEK1/2). An activated ERK dimer can regulate targets in the cytosol, but it can also translocate to the nucleus where it phosphorylates a variety of different transcription factors, which regulate gene expression ( Figure 3 ) [38] [39] [40] [41] [42] [43] . Diallyl mono-and polysulfanes target ERKs, p38 MAPKs and JNKs in general although there are differences with regard to the cell system or with regard to the length of the sulfur chain in the diallyl polysulfanes. Treatment of human lung adenocarcinoma cells with diallyl disulfide and diallyl trisulfide causes an early but transient activation of phospho-ERK1/2. Expression of phospho-ERK 1/2 peaked at 15 min after treatment but decreased thereafter [45] . Furthermore, phospho-JNK 1/2 increased upon treatment with diallyl disulfide and diallyl trisulfide, but with a different kinetics compared to ERK1/2. It markedly increased until 6 h after treatment and diminished at 24 h. In contrast, both polysulfanes did not alter the expression of p38 MAPK [44] . Using a specific JNK inhibitor clearly showed that JNK activation plays an essential role in diallyl disulfide and diallyl trisulfide induced apoptosis, whereas ERK 1/2 inhibitors, such as PD98059 and U0126, had no influence on apoptosis induction. A role for JNKs in the signaling pathways induced by diallyl sulfides was also found for human neuroblastoma cells (SH-SY5Y). Treatment of human neuroblastoma cells with diallyl disulfide resulted in a rapid increase (1 h) in the level of phospho-JNK. The level decreases after 12 h after treatment. The increase in phospho-JNK is rapidly followed by phosphorylation of c-Jun, which is a direct downstream target of JNK. A JNK inhibitor prevented neuroblastoma cells from apoptosis [12] . The same rapid and transient phosphorylation and activation of ERK1/2 and JNK1 was also reported for human prostate cancer cells treated with diallyl trisulfide. ERK 1/2 activation is followed by an elevated phosphorylation of the downstream target Elk-1, and c-Jun phosphorylation is observed as a result of a JNK activation. Interestingly, bcl-2 also appeared to be a substrate for JNK because a JNK inhibitor prevented bcl-2 phosphorylation and subsequently also apoptosis [45] . No such activation was found for p38 MAPK after treatment of human prostate cancer cells with diallyl disulfide and diallyl trisulfide. Similar results with regard to an increase in the level of phosphorylated ERK were also reported for human colon carcinoma cells. The amount of diallyl disulfide used for the treatment of these cancer cells however was rather high (100 µM and more) [46] . In contrast to these results, in a study with colon adenocarcinoma cells, down-regulation of ERK2 was found after treatment with diallyl sulfide [47] . Treatment of glioblastoma cells with either diallyl sulfide or diallyl disulfide induced an increase in the level of phosphorylated p38 MAPK and JNK1, whereas no such increase was found for other members of the MAPK family, namely p42 MAPK and p44 MAPK. The level of p38 MAPK and JNK remained the same, indicating that the expression of these proteins is not affected. Pretreatment of the glioblastoma cells with either MAPK specific inhibitors SB203580 or JNK inhibitor 1 completely blocked apoptosis after treatment with either diallyl sulfide or diallyl disulfide, demonstrating that p38 MAPK and JNK play key roles in the diallyl sulfide induced apoptosis [16] .
Another interesting observation is that diallyl trisulfide can abrogate a 12-O-tetradecanoylphorbol-13-acetate (TPA) induced tumor promotion in mouse skin. Analyzing the mechanism of this inhibition of tumor growth, it turned out that diallyl trisulfide diminished the TPA induced expression of c-Jun and c-Fos, the two downstream targets of JNKs. In this report, it was speculated that diallyl trisulfide might also modify critical residues in the DNA binding domains of c-Jun and c-Fos [48] . In contrast to thi report, human mammary cancer cells responded differently to diallyl disulfide treatment. Lei et al. found a decrease in the level of phosphorylated ERK, whereas the level of total ERK was not altered significantly. On the other hand, diallyl disulfide treatment led to an increase in phospho-JNK and phospho p38 MAPK [49] .
Although there are differences in the response of different cancer cells to diallyl polysulfide treatment, it seems to be a common event that the protein levels of the MAPKs remain mostly unaltered, but the level of phosphorylated, and thereby activated, kinases is elevated. On the other hand, the level, as well as the activity, of the down-stream targets c-Jun and c-Fos seems to be affected and the possible modification of critical residues in the DNA binding domains of c-Jun and c-Fos may be a direct effect.
Cellular signalling regulating cell cycle progression
The mammalian cell cycle is divided into four discrete phases: In the G 1 -phase of the cell cycle the cell prepares for upcoming events, i.e. providing amino acids, nucleotides, proteins etc. for the synthesis of DNA and RNA in the S-phase of the cell cycle. In the G 2 -phase, proteins that are necessary for cell division in the Mphase are synthesized. Progress in the eukaryotic cell cycle is driven by oscillation in the activity of cyclin-dependent kinases. The activity of the cyclin-dependent kinases is regulated a) by periodic synthesis and degradation of the regulatory subunits of the cyclin dependent kinases, the cyclins, b) by the level of inhibitor molecules, c) by phosphorylation and dephosphorylation of cyclindependent kinases, and d) by the subcellular localization. Different cyclins, together with different cyclin-dependent kinases, are involved in regulating cell cycle transition at specific stages. Cyclin D/cdk4/6 is necessary for G 1 -progression, cyclin E/cdk2 is required for G 1 /S phase transition, cyclin A/cdk2 for S-phase progression and cyclin A /B /cdk1 for the entry into M-phase. Inactivation of the cyclin-dependent kinases leads to either a cell cycle arrest or uncontrolled cell cycle progression. During the cell cycle, cdk1 is maintained in an inactive state by two kinases, namely Wee1 and Myt1. In the G 2 -and M-phase of the cell cycle, cyclin B is synthesized which associates with cdk1 to form the M-phase promoting factor MPF. As cells approach M-phase, the phosphatase cdc25C dephosphorylates and activates cdk1. In turn cdk1 phosphorylates and further activates cdc25C establishing a feedback amplification loop which efficiently drives the cell into mitosis. Many different stimuli, including growth factor withdrawal and DNA damage, lead to a signalling cascade inactivating the MPF complex ( Figure 4 ). DNA damage activates the DNA dependent protein kinase DNA-PK and ATM/ATR kinases, thereby inactivating cyclin B/cdk1. After entry of cells into mitosis, cyclin B of the MPF complex is degraded and cell division can take place ( Figure 5 ) [50] [51] [52] [53] [54] [55] [56] [57] .
It turned out that diallyl sulfides target members of the cell cycle signalling cascades, leading finally to growth arrest in the G 2 -phase of the cell cycle. While there are clearly cell type specific variations of the targeted molecules, in general, either cyclin B, cdc25C or chk1 are the main targets. It seems either the activity of the target molecules or the expression level is affected by diallyl sulfide treatment. In gastric cancer cells diallyl disulfide treatment resulted in a down-regulation of cdc25C [58] . For cyclin B1 the authors found a transient increase, as described for prostate and colon cancer cells. Also, in human leukemia cells, the level of cyclin B1 increased after treatment of the cells with diallyl tetrasulfide and cells arrested in an early phase of mitosis [59] .
A similar decrease in the protein level of cdc25C was found for colon cancer cells treated with diallyl di-, tri-or tetrasulfide [26] . RT-PCR analysis showed that the expression of chk1 and chk2 mRNA was unaltered in diallyl disulfide treated gastric cancer cells compared with untreated cells, whereas the phosphorylation at serine 345 of chk1 showed a significant increase with time. The phosphorylation of chk2, though, was not modified. Chk1 is a down-stream target of ATR, which showed an elevated expression of phosphorylated ATR, whereas the total level was not altered [58] . Thus from this study it was concluded that chk1 in particular is a target for diallyl disulfide. Wang et al. showed that cdc25C is rapidly down-regulated compared to its down-stream target, namely cyclin B1, which showed a biphasic response. Diallyl trisulfide treatment of skin cancer cells also resulted in a decrease of cdc25C and cdk1, which is a further indication that these alterations are common to most cancer cells [60] . Recently, in vitro phosphatase assays revealed that diallyl tetrasulfides are potent inhibitors of the cdc25A and cdc25C isoforms [61] . Since cdc25 family members harbor a cysteine residue in their active pocket, one might speculate that diallyl polysulfanes might destroy the activity by a redox reaction [62] . Thus, there seems to be a dual influence on cdc25C, on the protein level, and also on the enzyme activity.
From these data, it seems to be clear that diallyl sulfide treatment of cancer cells leads to a G 2 -arrest of the cell cycle, mainly by affecting the expression level and the activity of cdc25C. It is still unclear whether and how diallyl polysulfanes target these molecules directly or whether they act via reactive oxygen species (ROS) and DNA damage, which then induces the downstream pathway with ATR, chk1 and cdc25C. It remains an open question which is the key molecule for the switch from cell cycle arrest to apoptosis.
Diallyl polysulfanes and signalling cascades leading to apoptosis
Apoptosis or programmed cell death is an evolutionarily highly conserved physiological process for the regulation of cellular homeostasis and cell differentiation and defence [63] . Apoptosis can be initiated by the activation of the extracellular pathway which involves Fas and TRAIL receptors that can then form a deathinducing signaling complex called DISC (death inducing signalling complex). DISC contains Fas and FADD (Fas-associated via death domain), which recruit procaspase 8 to the complex. Procaspase 8 is activated by proteolysis to generate caspase 8, which then activates the down-stream caspases 3 and 7. Caspase 3 cleaves the DNA fragmentation factor ICAD (inhibitor of caspase-activated DNAse) in complex with CAD. CAD dissociates from ICAD, which leads to the activation of the DNAse activity of CAD. Alternatively, caspase 3 can activate procaspase 9 to induce apoptosis. Apoptosis can also occur via an intrinsic pathway, which can be induced by oncogenes, bcl-xL were decreased after treatment of the prostate cancer cells DNA damage, growth factor deprivation and hypoxia. One important player for the induction of the intrinsic pathway of apoptosis is the growth suppressor protein p53 [64] . DNA quality control proteins, such as the ataxia teleangiectasia mutated protein ATM and the checkpoint regulator 2, chk2, can directly phosphorylate and stabilize p53. p53 induces apoptosis by transcriptionally activating the pro-apoptotic bcl-2 family members and by repressing the anti-apoptotic bcl-2 family members. Other p53 targets are bax, bid, Noxa, Puma, PTEN, p53AIP1 and other genes that lead to an increase in reactive oxygen species (ROS). ROS induce a generalized oxidative damage of the mitochondria. Following this mitochondrial damage, pro-apototic bcl-2 family proteins are activated, allowing them to interact with and inactivate anti-apoptotic bcl-2 family members. Furthermore, mitochondrial damage leads to a release of cytochrome c from the mitochondria, which then activates caspase 9, followed by apoptosis.
Apoptosis is important in adult organisms to maintain normal cellular homeostasis. The pathway ( Figure 6 ) briefly described above integrates multiple physiological as well as pathological signals, which help to deal with infectious agents, DNA damage, cell stress and oncogene activation. Defects in the apoptotic pathways may be the cause for a disease. Insufficient apoptosis can manifest cancer or autoimmunity. On the other hand, apoptosis inducing agents may be suitable therapeutics to fight cancer and auto-immune diseases [65] [66] [67] . Diallyl sulfides are very potent for the induction of apoptosis of different cancer cells. Nonetheless, target molecules vary for different cancer types and, moreover, different diallyl sulfides generate a different outcome depending on the length of the sulfur chain.
From a number of studies, it is clear now that cancer cells are more susceptible to the treatment with diallyl sulfides than normal cells [59, 68, 69] . Furthermore, the number of sulfur atoms has a significant impact on their biological activities. Diallyl trisulfide is significantly more effective than diallyl disulfide which in turn is more active than diallyl sulfide [68] . In human lung cancer cells, it was shown that diallyl trisulfide treatment resulted in induction of pro-apoptotic bax and bak proteins, whereas the levels of the antiapoptotic proteins bcl-2 and bcl-xL were markedly decreased [68] . Although a marked increase in the level of the bid protein was evident after diallyl trisulfide treatment of lung cancer cells, it turned out that bid knock-out cells are equally sensitive to diallyl trisulfide-induced apoptosis, indicating that bid is dispensable for the induction of apoptosis. Down-regulation of bax and bak by siRNA technology conferred a significant protection against diallyl trisulfide-induced apoptosis [68] .
In another study with human lung adenocarcinoma cells, diallyl monosulfide turned out to be inactive in inducing cell cycle arrest and apoptosis even at a concentration of 1mM. In contrast, diallyl disulfide and diallyl trisulfide treatment of the lung cancer cells resulted in apoptosis in a dose-dependent manner [44] , supporting the idea that the length of the sulfur chain in the diallyl polysulfanes is an important determinant for the response of the cells. Treatment of these lung cancer cells for 24 h led to a decrease in the expression of bcl-2, but not that of bcl-xL. In another study with lung cancer cells (H1299), diallyl disulfide treatment led to a slight increase in the level of bax, whereas bcl-2 showed a significant decrease. Northern blotting experiments also revealed that the expression of bcl-2 was down-regulated at the mRNA level [70] . It was further shown that diallyl disulfide enhanced the expression of Fas in a dose dependent manner. Interestingly, diallyl trisulfide was inactive in the induction of Fas expression [44] . This finding shows that the extrinsic pathway of apoptosis via the CD95/Apo-1 death receptor is also activated in lung cancer cells, however, specifically by diallyl disulfide. Together with the data described above for lung cancer cells, it seems to be clear that both the extracellular as well as the intracellular pathways of apoptosis are induced by diallyl polysulfanes. This induction, however, can be cell specific and it can also be influenced by the chemical structure and the number of sulfur atoms of the polysulfanes. It was an interesting observation that normal lung cancer cells did not respond to induction of bax and bak and down-regulation of bcl-2 and bcl-xL, supporting the idea that different targeting and response of pro-and anti-apoptotic pathways are responsible for the different outcomes in cancer cells and normal cells.
Anaplastic thyroid carcinoma is one of the most lethal solid tumors of the thyroid gland [71] . Diallyl sulfide treatment of these tumor cells resulted in a G 2 /M phase arrest followed by apoptosis. This treatment led to an increase in the level of bax and a decrease of bcl-2 [72] indicating that alterations in the bax/bcl-2 ratio are not restricted to lung cancer. Furthermore, diallyl sulfide treatment of anaplastic thyroid carcinoma cells led to cytochrome c release from mitochondria into the cytosol and the expression of the cleaved and activated caspase-9 and caspase-3 [72] , which is an indication for the induction of the intrinsic pathway of apoptosis.
The analysis of hormone-responsive and non-responsive prostate cancer cells revealed that diallyl trisulfide treatment causes apoptosis in these prostate cancer cells irrespective of their androgen responsiveness [73] . In agreement with results from other normal, non-transformed cells, normal prostate epithelial cells are significantly more resistant to diallyl trisulfide-induced apoptosis. Diallyl trisulfide treatment of prostate cancer cells led to a collapse of the mitochondrial membrane potential whereas in normal prostate epithelial cells the mitochondrial membrane potential was resistant against diallyl trisulfide treatment. The levels of bcl-2 and with diallyl trisulfide, whereas there was a modest increase in the level of bak. There was no effect on the level of the bid protein.
Again, no such effect was observed for normal prostate epithelial cells, indicating that the block in apoptosis induction is mediated by factors upstream of the bcl-2 family of proteins. Over-expression of bcl-2 and bcl-xL had no effect on the diallyl trisulfide-induced apoptosis whereas bak and bax knockdown conferred a significant protection against apoptosis. In summary, these results indicated that bcl-2 and bcl-xL are not essential for diallyl trisulfide induced apoptosis, but bak and bax are clearly targets for diallyl trisulfide.
The pro-apoptotic activity of bad is regulated by phosphorylation [28] . In its dephosphorylated state, bad is localized to the outer mitochondrial membrane where it binds to and antagonizes the antiapoptotic bcl-2 family of proteins, such as bcl-xL. Phosphorylation of bad causes its cytoplasmic sequestration owing to increased binding to 14-3-3 proteins. This binding prevents the interaction of bad with bcl-2 family members. Treatment of human prostate cancer cells with diallyl trisulfide resulted in a reduced binding of bad to 14-3-3β protein and a forced translocation of bad to the mitochondria. Reduced phosphorylation of bad seems to be due to inactivation of the Akt kinase, which is responsible for bad phosphorylation [74] . The observations in cultured cancer cells were confirmed in an animal model of a prostate cancer cell xenograft in athymic mice. Tumors of mice treated with diallyl trisulfide exhibited an elevated expression of bak and bcl-xL proteins and a decrease in the level of bid protein compared with the same tumors from untreated mice [75] .
Diallyl tetrasulfide is the most recent but rarely investigated polysulfide. It is a promising compound because it was shown that the activity of the diallyl polysulfanes increases with increasing length of the sulfur chain. Recently, diallyl tetrasulfide was used for the treatment of human leukemia cells [59] . Diallyl tetrasulfide selectively induced apoptosis in these cells without affecting peripheral blood mono-nuclear cells from healthy donors. Apoptosis in cancer cells was accompanied by an early activation of bak followed by bax activation after prolonged treatment of leukemia cells with diallyl tetrasulfide. Furthermore, the level of bcl-xL rapidly decreased concomitant with bak activation. Bcl-2 cleavage was observed only after longer exposure to diallyl tetrasulfide.
Concomitant with the bcl-2 decrease and bax activation, the level of phosphorylated bad decreased. These results are consistent with the observations in most solid tumors. The time shift in the activation of the two proapoptotic factors implies two independent activities of bax and bak. Caspase-3, caspase-8 and caspase-9 were also activated in a time-dependent manner. Experiments with specific caspase-9 and caspase-8 inhibitors revealed that both inhibitors blocked apoptosis; here, the caspase-9 inhibitor was more efficient [68, 69] .
Investigating diallyl sulfide and diallyl disulfide for their effects on human primary neurons and neuroblastoma SH-SY5Y cells, it turned out that the primary neurons were by far more resistant to apoptosis induction than the neuroblastoma cells [69] . Cells treated with both diallyl sulfides showed an increase in bax and a decrease in bcl-2 expression. This alteration in the bax:bcl-2 ratio is followed by cytochrome c release from mitochondria into the cytosol, increase in the Smac/Diablo level in the cytosol, and a decreased expression of IAPs. The altered bax:bcl-2 ratio, cytochrome c and Smac/Diablo release from mitochondria are all consistent with the activation of the intrinsic pathway of apoptosis. Consequently, diallyl sulfide and diallyl disulfide treated cells also resulted in caspase-9 and caspase-3 activation. In addition, the down-stream factors ICAD and CAD were activated [69] .
Survivin, a member of the inhibitor of apoptosis protein family, is aberrantly expressed in cancer cells but undetected in normal cells [76] . At a concentration of 200 µM diallyl disulfide and 50 µM diallyl trisulfide, an up-regulation of survivin was observed after 24 h of incubation, whereas at lower concentrations, no such increase was observed [44] .
The role of p53 in the diallyl polysulfane-induced apoptosis is not yet clear. Song et al. [77] reported no alteration in the level of p53 in human colon cancer cells treated with diallyl disulfide, whereas, Busch et al. [26] found an increase in p53 level. On the other hand, down-regulation of p53 by siRNA technology prevented the accumulation of apoptotic cells supporting the idea that p53 is essential for apoptosis induction [77] . It was also shown, however, that p53-negative colon carcinoma cells go into apoptosis after treatment with diallyl disulfide [26] , suggesting that p53 is not absolutely necessary for induction of apoptosis.
Diallyl trisulfide caused apoptosis in androgen independent growing prostate cancer cells which lack functional p53 [45] . This observation is in agreement with results from p53 -/human colon carcinoma cells [26] . Using p53 wild-type and p53 negative lung cancer cells, it was further shown that cells expressing wild-type p53 were more sensitive to apoptosis induction than p53 negative cells, which means that p53 plays at least some role in the apoptotic response of cells to diallyl di-and trisulfide treatment [70] .
Thus, from these numerous studies, an increase in the level of bax seems to be a common event. In most cases, an increase in bak and a decrease in the level of bcl-2 and bcl-xL were also found. In addition to the influence of diallyl polysulfanes on the level of these proteins, an influence on the phosphorylation, protein protein interactions and a redistribution of proteins, in particular at the mitochondria, were also reported. Furthermore, an effect on the enzymatic activities of the caspases seems to be a common response within cells. It still remains an open question however whether diallyl polysulfanes exert their alterations directly on the affected proteins or rather indirectly, for instance via regulating ROS levels.
Concluding remarks and future perspectives:
There is now sufficient evidence to conclude that diallyl polysulfanes are effective inhibitors of cancer cells, including those of brain, breast, lung, colon, stomach and prostate cancer. It is well known that cancer cells have a very high metabolic turnover, as they require much energy to divide for rapid growth. It is also becoming evident that diallyl polysulfanes produce ROS in these rapidly dividing cancer cells, which promote their death by targeting a number of different intracellular signal transduction cascades. The diallyl disulfide-induced ROS are now appearing as an overture to DNA damage, cell cycle arrest, decreased cell proliferation and induction of apoptosis in most cancer cells. The fact that these compounds also increase ER stress, activate stress kinases and cysteine proteases, and induce detoxifying enzymes, emphasizes their potential as natural anticancer agents.
Certain areas of the diallyl polysulfane inhibitory effects of cancer cells, however, are still poorly understood. Some open questions that still remain include: Is diallyl polysulfane-induced DNA damage an early or late event? What are the exact signaling mechanisms underlying ER stress-induced cell death? Do ER stress mediated processes converge into the intrinsic mitochondrial pathway of apoptosis? Are there additional redox interactions of the polysulfanes with enzymes such as cdc25C or transcription factors, such as c-Fos or c-Jun? Can new drugs be produced on the basis of polysulfanes, but with other, probably more active, side chains?
